Your search returned 464 results.

Results
	101.	Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery. [electronic resource] by Chilton, C H Freeman, J Baines, S D Crowther, G S Nicholson, S Wilcox, M H Producer: 20140331 In: The Journal of antimicrobial chemotherapy vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	102.	Oritavancin: first global approval. [electronic resource] by Markham, Anthony Producer: 20150827 In: Drugs vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011-2014). [electronic resource] by Mendes, R E Sader, H S Smart, J I Castanheira, M Flamm, R K Producer: 20180214 In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	104.	Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review. [electronic resource] by Van Bambeke, Françoise Producer: 20160916 In: Drugs vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	105.	Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC-ESI-MS. [electronic resource] by Wang, Xiaoming Paul, Jonathan A Nanovskaya, Tatiana N Hankins, Gary D V Ahmed, Mahmoud S Producer: 20150421 In: Journal of pharmaceutical and biomedical analysis vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	106.	Oritavancin Pharmacokinetics and Bone Penetration in Rabbits. [electronic resource] by Lehoux, Dario Ostiguy, Valerie Cadieux, Cordelia Malouin, Mireille Belanger, Odette Far, Adel Rafai Parr, Thomas R Producer: 20160627 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing. [electronic resource] by Yan, Qun Karau, Melissa J Patel, Robin Producer: 20190206 In: Journal of clinical microbiology vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. [electronic resource] by García-Garrote, F Cercenado, E Alcalá, L Bouza, E Producer: 19981022 In: Antimicrobial agents and chemotherapy vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	Vibativ (telavancin) for complicated skin and skin structure infections. [electronic resource] by Ghasri, Pedram Scheinfeld, Noah S Producer: 20110107 In: Skinmed vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	110.	Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program. [electronic resource] by Mendes, Rodrigo E Sader, Helio S Flamm, Robert K Farrell, David J Jones, Ronald N Producer: 20150515 In: Antimicrobial agents and chemotherapy vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	111.	Kidney injury associated with telavancin dosing regimen in an animal model. [electronic resource] by Tam, Vincent H Ledesma, Kimberly R Bowers, Dana R Zhou, Jian Truong, Luan D Producer: 20160104 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains. [electronic resource] by Zelenitsky, S A Karlowsky, J A Zhanel, G G Hoban, D J Nicas, T Producer: 19970731 In: Antimicrobial agents and chemotherapy vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. [electronic resource] by Baltch, A L Smith, R P Ritz, W J Bopp, L H Producer: 19981109 In: Antimicrobial agents and chemotherapy vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	114.	Study on the in-vitro activity of LY333328 against gram-positive cocci. [electronic resource] by Mezzatesta, M L Bonfiglio, G De Angelis, L Stefani, S Russo, G Producer: 19981117 In: The Journal of antimicrobial chemotherapy vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	115.	Outpatient parenteral antimicrobial therapy: Recent developments and future prospects. [electronic resource] by Török, M Estee Chapman, Ann L N Lessing, M P Albert Sanderson, Frances Seaton, R Andrew Producer: 20110124 In: Current opinion in investigational drugs (London, England : 2000) vol. 11 Availability: No items available. Save to lists Add to cart (remove)
	116.	Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteers. [electronic resource] by Shaw, Jeng-Pyng Cheong, Jonathan Goldberg, Michael R Kitt, Michael M Producer: 20101124 In: Antimicrobial agents and chemotherapy vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	117.	Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains. [electronic resource] by Abdelhady, Wessam Bayer, Arnold S Gonzales, Rachelle Li, Liang Xiong, Yan Q Producer: 20170919 In: Antimicrobial agents and chemotherapy vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	118.	Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. [electronic resource] by Cooper, R D Snyder, N J Zweifel, M J Staszak, M A Wilkie, S C Nicas, T I Mullen, D L Butler, T F Rodriguez, M J Huff, B E Thompson, R C Producer: 19960905 In: The Journal of antibiotics vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	119.	Oritavancin: a new avenue for resistant Gram-positive bacteria. [electronic resource] by Mercier, Renee-Claude Hrebickova, Lenka Producer: 20070116 In: Expert review of anti-infective therapy vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	120.	Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. [electronic resource] by Nailor, Michael D Sobel, Jack D Producer: 20100223 In: Infectious disease clinics of North America vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 464 results.